News

Wacker Chemie said that the expansion will enable it to accommodate its customers’ growing demand for biotechnologically manufactured pharmaceuticals. Biologics are used to treat, among other things, cancer,

Reportedly, the British-Swedish pharma major had filed two lawsuits against Sun Pharma and its US subsidiary on February 26 in a federal court in Trenton, New Jersey, and

As per the agreement, Nabi will be entitled to receive an upfront payment of $40m and GSK will be granted an option to exclusively in-license NicVAX on a

The grant has been designed to shrink technology found in large hospital hematology analyzers, typically the size of small refrigerators, to a tiny, palm-sized device. The emergency blood

Neuroquell works by inhibiting or stopping the nerve pain impulse signals as they travel from one nerve cell to another, (called a synapse). Claire Ellen Products claimed that

Stefan Oschmann, president of emerging markets at Merck, said that the company’s endeavors of this proposed expansion will lead to increase in sales in the region by 30%,

Nanotechnologies have been proven as a valuable adjunct to the development of new therapeutics. Nanoparticles provide a much larger surface area thereby increasing the dissolution rate resulting in

The technology allows a single in-office minimally invasive surgical procedure. The patent also allows the device to deliver medication or therapeutic agents to the uterine cavity. ContraMed has

Reportedly, the entreprise value of Merial has been fixed at $8bn and the entreprise value of Intervet/Schering-Plough at $8.5bn, leading to a true-up payment of $250m to Merck